USA Proton Therapy Market to exceed USD 15 Billion by 2021, with CAGR of 6.04 Percent

USA Proton Therapy Market News Analyst View: USA Proton Therapy Market to exceed USD 15 Billion by 2021, with CAGR of 6.04 Percent For More Information: http://www.renub.com/usa-proton-therapy-market-to-exceed-usd-15-billion-by-2021-withcagr-of-6-04-percent-23-nd.php Download full Report: http://www.renub.com/united-states-proton-therapy-market-and-forecast-reimbursementpolicy-patients-treated-at-proton-therapy-centers-1045-p.php A new report by Renub Research, titled “United States Proton Therapy Market & Forecast, Reimbursement Policy and Patients Treated at Proton Therapy Centers” provides comprehensive insight of United States Proton Therapy Market. Proton therapy evolves as a prime radiation treatment modality. The compliance of proton therapy into clinical practice for more than 2 decades in United States makes it one of the advanced radio therapy tool to fight deadly cancerous tumor like Brain cancer, Eye cancer, Prostate cancer, Colon and rectal cancer, Breast cancer etc. In recent times, many research institutes and hospitals are investing in proton therapy to make proton therapy technology more affordable and accessible to patients. Rising cancer prevalence and increasing waiting list of high risk cancer patients shows high credential and acceptance of proton therapy in United States.

Proton Therapy Market in United States The potential demand of proton therapy market in United States for the year 2021 is expected to be higher than USD 15 Billion, growing with a CAGR of 6.04 percent. USA holds the major market share in Global Proton Therapy Market.

Proton Therapy is far better than Standard Therapy

Page 1 of 2

USA Proton Therapy Market to exceed USD 15 Billion by 2021, with CAGR of 6.04 Percent

There was paradigm shift in terms of utilization of radiotherapy over the several decades and photons come into existence with absence of randomized clinical trials. The adoption of photons (radiotherapy) continues to strive to limit the dose to normal tissues. The core reason for this is the unable to control the exit dose downstream from the target (tumor), which is a physical limitation of the megavoltage photon beam. Then, proton beam therapy (PBT) is come under attention. Contrasting photons, protons deposit almost all of their energy at a defined and controllable depth from the skin surface, specifically avoiding the exit dose. Therefore it mitigates the risk of damage to nearby healthy tissue and vanish negative side effects.

Proton Therapy provides Treatment Possibility for Recurrent Lung Cancer in United States According to recent study by Multidisciplinary Thoracic Cancers Symposium, the major death of cancer patients in United States caused by lung cancer than any other type of cancer, because of its Invasive form and likelihood of recurrence. In historical facts, recurrences have been exception to treat; due to majority of these patients are not opt for surgery. The most patients with reoccurrence lung cancer offered palliative options as a last resort to manage pain. Proton therapy, permit radiation oncologists to recognize normal tissues and spare them while delivering escalated, curative doses of radiation to nearby tumors. Moreover, IMPT has ability to exactly target a tumor.

Life Science News: http://www.renub.com/life-science-1-n.php

Renub Research - North America

Renub Research - Asia

Rajat Gupta

Ankit Mishra

225 Kristie Ln, Roswell

C – 86, Sector – 10

Georgia 30076, United States

Noida 201301, India

Tel: +1-678-302-0700

Tel: +91-120-421-9822

Email: info@renub.com

www.renub.com

Page 2 of 2

Turn static files into dynamic content formats.

Create a flipbook

USA Proton Therapy Market to exceed USD 15 Billion by 2021, with CAGR of 6.04 Percent

Published on Apr 26, 2017

Renub Research

A new report by Renub Research, titled “United States Proton Therapy Market & Forecast, Reimbursement Policy and Patients Treated at Proton Therapy Centers” provides comprehensive insight of United States Proton Therapy Market. Proton therapy evolves as a prime radiation treatment modality. The compliance of proton therapy into clinical practice for more than 2 decades in United States makes it one of the advanced radio therapy tool to fight deadly cancerous tumor like Brain cancer, Eye cancer, Prostate cancer, Colon and rectal cancer, Breast cancer etc. In recent times, many research institutes and hospitals are investing in proton therapy to make proton therapy technology more affordable and accessible to patients. Rising cancer prevalence and increasing waiting list of high risk cancer patients shows high credential and acceptance of proton therapy in United States. For More Information: http://www.renub.com/usa-proton-therapy-market-to-exceed-usd-15-billion-by-2021-with-cagr-of-6-